Matches in SemOpenAlex for { <https://semopenalex.org/work/W3014700813> ?p ?o ?g. }
- W3014700813 endingPage "239" @default.
- W3014700813 startingPage "239" @default.
- W3014700813 abstract "<ns4:p>The discovery that glucagon-like peptide 1 (GLP-1) mediates a significant proportion of the incretin effect during the postprandial period and the subsequent observation that GLP-1 bioactivity is retained in type 2 diabetes (T2D) led to new therapeutic strategies being developed for T2D treatment based on GLP-1 action. Although owing to its short half-life exogenous GLP-1 has no use therapeutically, GLP-1 mimetics, which have a much longer half-life than native GLP-1, have proven to be effective for T2D treatment since they prolong the incretin effect in patients. These GLP-1 mimetics are a desirable therapeutic option for T2D since they do not provoke hypoglycaemia or weight gain and have simple modes of administration and monitoring. Additionally, over more recent years, GLP-1 action has been found to mediate systemic physiological beneficial effects and this has high clinical relevance due to the post-diagnosis complications of T2D. Indeed, recent studies have found that certain GLP-1 analogue therapies improve the cardiovascular outcomes for people with diabetes. Furthermore, GLP-1–based therapies may enable new therapeutic strategies for diseases that can also arise independently of the clinical manifestation of T2D, such as dementia and Parkinson’s disease. GLP-1 functions by binding to its receptor (GLP-1R), which expresses mainly in pancreatic islet beta cells. A better understanding of the mechanisms and signalling pathways by which acute and chronic GLP-1R activation alleviates disease phenotypes and induces desirable physiological responses during healthy conditions will likely lead to the development of new therapeutic GLP-1 mimetic–based therapies, which improve prognosis to a greater extent than current therapies for an array of diseases.</ns4:p>" @default.
- W3014700813 created "2020-04-10" @default.
- W3014700813 creator A5025668710 @default.
- W3014700813 creator A5049969661 @default.
- W3014700813 creator A5080463002 @default.
- W3014700813 date "2020-04-06" @default.
- W3014700813 modified "2023-10-01" @default.
- W3014700813 title "Recent advances in understanding the role of glucagon-like peptide 1" @default.
- W3014700813 cites W1610120196 @default.
- W3014700813 cites W1828613304 @default.
- W3014700813 cites W1959592008 @default.
- W3014700813 cites W1966068360 @default.
- W3014700813 cites W1966122159 @default.
- W3014700813 cites W1966991896 @default.
- W3014700813 cites W1973577866 @default.
- W3014700813 cites W1977378187 @default.
- W3014700813 cites W1985305554 @default.
- W3014700813 cites W1994141137 @default.
- W3014700813 cites W2005088542 @default.
- W3014700813 cites W2010671489 @default.
- W3014700813 cites W2013082477 @default.
- W3014700813 cites W2013804474 @default.
- W3014700813 cites W2021022471 @default.
- W3014700813 cites W2022106893 @default.
- W3014700813 cites W2028502361 @default.
- W3014700813 cites W2030198351 @default.
- W3014700813 cites W2038463744 @default.
- W3014700813 cites W2041346929 @default.
- W3014700813 cites W2041624484 @default.
- W3014700813 cites W2043673143 @default.
- W3014700813 cites W2054979846 @default.
- W3014700813 cites W2060043747 @default.
- W3014700813 cites W2060409973 @default.
- W3014700813 cites W2069884615 @default.
- W3014700813 cites W2076805031 @default.
- W3014700813 cites W2080785707 @default.
- W3014700813 cites W2085594547 @default.
- W3014700813 cites W2091979481 @default.
- W3014700813 cites W2096045658 @default.
- W3014700813 cites W2100839579 @default.
- W3014700813 cites W2103052169 @default.
- W3014700813 cites W2105726125 @default.
- W3014700813 cites W2106036385 @default.
- W3014700813 cites W2106709311 @default.
- W3014700813 cites W2109769875 @default.
- W3014700813 cites W2113094401 @default.
- W3014700813 cites W2115860183 @default.
- W3014700813 cites W2117711479 @default.
- W3014700813 cites W2120890050 @default.
- W3014700813 cites W2121497054 @default.
- W3014700813 cites W2124831863 @default.
- W3014700813 cites W2126798978 @default.
- W3014700813 cites W2131873059 @default.
- W3014700813 cites W2132295069 @default.
- W3014700813 cites W2132600402 @default.
- W3014700813 cites W2140666083 @default.
- W3014700813 cites W2142395926 @default.
- W3014700813 cites W2149717292 @default.
- W3014700813 cites W2153323738 @default.
- W3014700813 cites W2154383633 @default.
- W3014700813 cites W2159416991 @default.
- W3014700813 cites W2161155577 @default.
- W3014700813 cites W2163837966 @default.
- W3014700813 cites W2168620887 @default.
- W3014700813 cites W2169510766 @default.
- W3014700813 cites W2169558934 @default.
- W3014700813 cites W2169914389 @default.
- W3014700813 cites W2178341058 @default.
- W3014700813 cites W2248623090 @default.
- W3014700813 cites W2270971263 @default.
- W3014700813 cites W2282578582 @default.
- W3014700813 cites W2319839537 @default.
- W3014700813 cites W2334243568 @default.
- W3014700813 cites W2343523076 @default.
- W3014700813 cites W2409172672 @default.
- W3014700813 cites W2409181047 @default.
- W3014700813 cites W2425644022 @default.
- W3014700813 cites W2503742534 @default.
- W3014700813 cites W2509773773 @default.
- W3014700813 cites W2519031788 @default.
- W3014700813 cites W2519510391 @default.
- W3014700813 cites W2589758965 @default.
- W3014700813 cites W2590664415 @default.
- W3014700813 cites W2592545469 @default.
- W3014700813 cites W2593571692 @default.
- W3014700813 cites W2618659953 @default.
- W3014700813 cites W2744843428 @default.
- W3014700813 cites W2752707491 @default.
- W3014700813 cites W2754041380 @default.
- W3014700813 cites W2756380409 @default.
- W3014700813 cites W2778699832 @default.
- W3014700813 cites W2790068096 @default.
- W3014700813 cites W2790166925 @default.
- W3014700813 cites W2790574529 @default.
- W3014700813 cites W2790605627 @default.
- W3014700813 cites W2791055036 @default.
- W3014700813 cites W2794167718 @default.
- W3014700813 cites W2807279220 @default.